4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-022045
President and CEO sold 7,230 shares at $9.63 ($69,625)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luly Jay R. President and CEO | 2023-12-05 | Sale | −7,230 | $9.63 | $69,625 | 806,793 | D |
| Open-market sales · 7,230 sh · avg $9.63 · $69,625 | |||||||
Loading xslF345X05/form4.xml…